Smith & Nephew plc (LON:SN.)

Market Cap	8.73B
Revenue (ttm)	4.64B
Net Income (ttm)	329.09M
Shares Out	875.03M
EPS (ttm)	0.38
PE Ratio	26.58
Forward PE	13.86
Dividend	0.28 (2.81%)
Ex-Dividend Date	Mar 27, 2025

Volume	2,106,744
Average Volume	3,138,204
Open	998.00
Previous Close	991.40
Day's Range	995.40 - 1,006.50
52-Week Range	8.87 - 12.45
Beta	0.65
RSI	43.43
Earnings Date	Jul 31, 2025

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1856
• Employees: 17,349
• Stock Exchange: London Stock Exchange
• Ticker Symbol: SN.

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Financial numbers in USD